FreeCME

6th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

/ Print /
| ShareMore
/ Text Size +
12/11/21 8:00 am EDT
InterContinental New York Times Square + Virtual
United States


The 6th Annual International Congress on Immunotherapies in Cancer™ Focus on Practice-Changing Application is an intensive, 1-day interactive program that will provide a comprehensive review of clinical trial-derived and real-world data that are most relevant to the application of these novel strategies for the clinician who manages some of the most difficult-to-treat forms of cancer. Topics of particular interest will be new developments in biomarkers, recent immunotherapy combinations, and strategies for mitigating adverse events.

Learning Objectives 

The learning objectives of this program are:

  • Describe strategies for stratifying risk and predicting response to immunotherapeutic regimens in cancer management
  • Correlate the mechanisms of action for immunotherapeutic strategies to their application in the treatment of malignancy
  • Evaluate newer and emerging data from clinical trials investigating the efficacy and safety of cancer immunotherapy regimens
  • Implement practical strategies for the immunotherapy management of solid and hematologic malignancies

Use code ICIC35CME for 35 percent off!

Target Audience

The target audience for this activity is directed toward medical oncologists, oncology nurse practitioners and nurses, and pharmacists who treat patients with cancer. You are encouraged to participate if your practice primarily requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and your evolving role in the treatment of patients with cancer. Nurses, physician assistants, fellows, researchers, and other health care professionals interested in the treatment of cancer are invited to participate.

Date

December 11, 2021

8:00 AM – 4:00 PM ET

Hybrid Interactive Conference

 

Program Chairs

Mario Sznol, MD
Professor of Medicine (Medical Oncology)
Yale School of Medicine
Program Leader, Melanoma
Co-Leader, Cancer Immunology Program
Yale Cancer Center
New Haven, CT

 

Charu Aggarwal, MD, MPH
Leslye M. Heisler Associate Professor for Lung Cancer Excellence
Hospital of the University of Pennsylvania
Philadelphia, PA